1.1
Purpose of Reporting and Surveillance
1.
To assess the magnitude of lead exposure in Oregon.
2. To identify all tested individuals with elevated blood lead levels (EBLL).
3. To identify the sources of lead exposure for individuals with EBLL and to identify, notify, and evaluate others who may be at risk from those sources. 4 . To ensure that individuals with EBLL receive proper medical management, including follow-up, until their blood lead concentration drops to acceptable levels.
5. To ensure that adequate environmental follow-up occurs, to reduce or eliminate the risk of further lead exposure from identified sources for the affected child and any family members, playmates, etc. who could also be exposed to the same source.
6. For occupational exposures, to ensure that the Oregon Occupational Safety and Health Division (OR-OSHA) is aware in a timely manner.
Laboratory Disease Reporting Requirements
1. Laboratories must report all blood lead test results directly to the local health authority or Oregon Health Authority (OHA) within seven days [333-018-0015 4(d)]. Lead poisoning (>= 5ug/dL under 18 years of age, >= 10 µg/dL over 18 years) must be reported within one local health department working day [333-018-0015 4(c)]; results may be sent electronically or faxed to (971) 673-0457.
2. Oregon law requires labs that send an average of >30 records per month to OHA to submit the data electronically. Please contact OHA at 971-673-1111 for Electronic Laboratory Reporting (ELR) initiation, assistance and approval.
Clinician Disease Reporting Requirements
1. Clinicians using point-of-care portable analyzers for blood lead testing are required to report all blood lead test results directly to the local health authority or OHA within seven days [333-018-0015 4(d)]. Lead poisoning (see definition) must be reported within one local health department working day [333-018-0015 4(c)]; results can be sent electronically or faxed to (971) 673-0457. For more information on reporting, contact OHA at 971-673-0440.
Local Health Authority Reporting and Follow-Up Responsibilities 10/18/18
1. OHA will refer childhood EBLL reports received directly from labs or clinicians to Local Public Health Authorities (LPHA) for follow-up. If the LPHA is notified directly of an EBLL test result, they should report the case to OHA via the Oregon Public Health Epidemiologists' User System (Orpheus). 
LEAD POISONING AND ITS EPIDEMIOLOGY

Background
Lead is a naturally occurring soft metal found in rocks and soil. Throughout history, it has been used for a variety of purposes (e.g. glazing pottery, soldering). Characteristic features of lead toxicity, including anemia, colic, and coma, were noted by Hippocrates in ancient times. 1 Lead serves no useful biologic purpose in the human body, and recent evidence demonstrates that multiple health effects can occur at lead levels once considered safe. 2 The insidious nature of lead poisoning means that the only way to know if an adult or child has an EBLL is to perform a blood test. Lead poisoning continues to be an important environmental and occupational health problem. For more information on sources of lead exposure, see Section 8.
Description of Illness
A. Absorption and Distribution
Ingestion and inhalation are the typical routes of lead exposure. The most common source of lead exposure for children is ingestion of lead-containing dust. The rate of lead uptake is affected by an individual's developmental stage, route of exposure, and nature of the lead compounds to which the individual is exposed. Nutritional status is also important; a healthy diet high in iron and calcium and low in fat may slow the rate of lead absorption. Absorption depends on the form of the lead. Inhaled, airborne lead is almost totally absorbed, while ingested lead absorption rates may vary from 10% in adults to 50% in children and pregnant women. Lead is absorbed more efficiently from dust from sanded lead-based paint than from whole paint chips. The most dangerous exposure is to lead vapors (formed whenever lead is melted) or other respirable lead compounds. Absorbed lead is detectable in blood, soft tissue and bone. The half-life of lead varies from about a month in blood, 1-1.5 months in soft tissue, and about 25-30 years in bone. 3 For the purposes of these guidelines, persons with EBLLs are considered to have lead poisoning. Lead poisoning can affect both children and adults, although the effects may vary markedly with age. It is convenient, albeit somewhat artificial, to divide lead poisoning into an acute disease that relates to current BLLs, and a chronic disease that relates to the cumulative effects of body lead burden. In both cases, the most prominent signs and symptoms are neurological. Bear in mind that persons with very high BLLs (70 μg/dL in children, ≥100 in adults) should be treated as medical emergencies, regardless of overt symptoms. Ingestion of a metallic object that may contain lead can result in an EBLL within hours. Ingestion of any object that may contain lead should be treated as a medical emergency and treatment should include a blood lead test and abdominal x-ray.
Form
B. Acute Disease
Acute exposure to lead generally means exposure for a short time, but at high levels. Blood lead levels increase quickly after an acute exposure. The most common symptom of acute lead poisoning is colicky abdominal pain evolving over days to weeks. Constipation, diarrhea, and nonspecific complaints of irritability, fatigue, weakness and muscle pain may also occur. These symptoms are seldom caused by BLLs less than 50 μg/dL. In more severe cases, warning signs of acute, serious brain swelling include vomiting, irritability, restlessness, tremors, and progressive drowsiness. These symptoms may herald the onset of seizures, coma, and possibly death. The BLLs associated with encephalopathy in children vary from study to study, but BLLs of 70-80 μg/dL or greater appear to indicate a serious risk. 3
C. Chronic Effects
Chronic lead exposure generally means exposure to lead over a long period. Recent studies suggest that lead absorption is harmful at any concentration and that no safe level of lead exposure exists. 2, 4 Relatively low blood lead levels rarely cause overt signs and symptoms, but such exposure can cause permanent damage-especially in young children-including decreased IQ, developmental delays and behavioral disturbances. In adults, late effects of chronic lead toxicity include chronic renal failure, hypertension, gout, and chronic encephalopathy. 5 
TESTING METHODS AND CASE DEFINITIONS
.S E DEFINITIONS, DIAGNOSIS, ABORATORY SERVICE
Testing Methods
Blood lead testing is the only acceptable laboratory test for screening and confirming lead poisoning. Venipuncture is preferred for specimen collection, but capillary testing is acceptable if care is taken to properly clean and prepare the finger. Capillary samples are easier to contaminate because of the possibility of lead containing dust and dirt on the hand or under the fingernails. All 10/18/18 capillary BLLs of  5 μg/dL (children or pregnant women) or higher must be followed with a confirmatory venous test.
Several tests have been found to be insensitive and/or imprecise as screening tests for lead and are not recommended. These include: erythrocyte protoporphyrin (EP) measured as either free erythrocyte protoporphyrin (FEP) or zinc protoporphyrin (ZPP); basophilic stippling; urine testing; and assays of hair or fingernail lead levels.
Case Definitions
In 1991, CDC defined BLLs of  10 μg/dL as the "level of concern" for children aged 1-5 years. Based on a growing body of studies of adverse health effects with BLLs less than 10 μg/dL, CDC changed the term "level of concern" to "reference value", to reinforce that there is not a recognized safe level of lead exposure. On May 13, 2012, CDC adopted the reference value of  5 μg/dL. OHA adopted the reference value of  5 μg/dL in 2016.
LPHAs are expected to conduct case management activities for children and pregnant and lactating women according to the public health action levels listed in Table 2 . LPHAs may request technical assistance from OHA in conducting case management activities as needed. OHA will provide and/or arrange periodic training to LPHA staff on case management procedures. The goal is to ensure that all children and pregnant and lactating women with a lead poisoning case receive the appropriate care.
Table 2. Lead Poisoning Case Definitions
*LPHAs are not expected to conduct case management activities for adults (with the exception of pregnant and lactating women). OHA conducts investigations for adult cases and will alert LPHAs only when there is concern for the health of other household members. 
SCREENING SCHEDULES AND MEDICAL MANAGEMENT
Anticipatory Guidance
Anticipatory guidance regarding lead hazard identification and risk reduction measures should be a routine part of an ongoing educational approach for pregnant women, children and their families. Medical providers should provide source identification and risk reduction educational materials. There is no safe level of lead and the majority of children and adults in the U.S. have blood lead levels less than 2 μg/dL. 6 Individuals should reduce lead exposure and maintain the lowest possible blood lead level.
Lead exposure during pregnancy is especially problematic as lead can cross the placenta and interfere with normal development of the fetal brain. Pregnant women can be exposed to lead through all of the sources described previously. Pregnant women or women likely to become pregnant should try to avoid exposure and maintain lead levels below 5 μg/dL and as low as possible. Anticipatory guidance should focus on decreasing the risk of exposure to lead by advising against activities such as remodeling or repainting the baby's room or restoring old furniture. For women exposed occupationally, discuss personal protective equipment and consider contacting the employer to encourage reducing exposure. OHA can assist with occupational exposures.
Screening Protocols for Children
All children should be assessed for risk of lead poisoning by administration of the Oregon Lead Risk Assessment Questionnaire (see below). This questionnaire should be administered at 1 and 2 years of age, or between 3 and 5 years of age if not previously screened. If the answer to any question is "Yes" or "Don't know," a blood lead test should be performed. Follow-up questions may be needed to clarify responses. Children who are enrolled in Medicaid are required to be tested (not screened) at 12 and 24 months. For more examples, see Table 5 , Section 8.
Screening Protocols for Pregnant and Lactating Women
The purpose of screening pregnant women is to identify women exposed to lead who can benefit from the knowledge of their lead exposure and prevent additional exposure or adverse effects to themselves or their fetuses. Identifying maternal lead exposure prior to conception or early in the pregnancy offers the most benefit to the fetus. The following questionnaire should be administrated at the earliest contact with the patient. If the answer to any question is "Yes" or "Don't know," a blood lead test should be performed. Follow-up questions may be needed to clarify responses. For more examples, see Table 5 , Section 8.
Diagnostic Blood Lead Testing
Blood lead testing should also be considered as part of a diagnostic work-up of any individual regardless of age with the following symptoms:
❖ Behavioral problems (applies to children): aggression, hyperactivity, attention deficit, school problems, learning disabilities, excessive mouthing or pica behavior and other behavior disorders. 10/18/18 ❖ Developmental problems (applies to children): growth, speech and language delays and/or hearing loss. ❖ Symptoms or signs consistent with lead poisoning: irritability, headaches, vomiting, seizures or other neurological symptoms, anemia, loss of appetite, abdominal pain/cramping or constipation. ❖ Ingestion of foreign body.
4.6
Follow-up for Elevated Blood Lead Results
A. Childhood Cases
Any capillary BLL test result at or above 5 μg/dL must be confirmed with a venous sample. The higher the BLL on the capillary test, the more urgent the need for venous confirmatory testing. Exception to confirmatory testing schedule: If recent known exposure (e.g. foreign body ingestion, recent remodeling), confirm as soon as possible for all blood lead levels. Table 3 is to be used as guidance. Case managers and clinicians should consider individual patient characteristics and caregiver capabilities and adjust the frequency of follow-up tests accordingly. • Ensure follow-up testing by established timeframe.
• Include history of EBLL in problem list of child's permanent medical record.
• See CDC guidelines for more medical management recommendations.
LPHA case management:
• Contact caregiver regarding child's BLL.
• 
Case Management for BLLs in Children
• Send environmental sampling results (and those performed by OHA) and follow-up recommendations in letter to family • Send copy of questionnaire to and follow-up letter to clinician.
• Refer family to WIC, social services, public assistance, early intervention or housing remediation services if applicable and/or available.
• Ensure follow-up testing by established timeframe.
10-19
As soon as possible, or within 7 days 3 months Clinician case management: ALL OF THE ABOVE.
LPHA case management: ALL OF THE ABOVE.
20-44
As soon as possible, or within 7 days 1 month Clinician case management: ALL OF THE ABOVE, PLUS:
• Children with BLLs > 20 μg/dL should have a medical examination.
• Conduct neurodevelopmental monitoring. LPHA case management: ALL OF THE ABOVE.
45-59
As soon as possible, or within 2 days Chelation* with subsequent follow-up.
Clinician case management: ALL OF THE ABOVE, PLUS:
• Chelation therapy. Follow-up testing schedule determined by medical provider.
60-69
As soon as possible, or within 1 day Chelation* with subsequent follow-up
Clinician case management: ALL OF THE ABOVE, PLUS:
 70
Immediately as an emergency lab test Chelation* with subsequent follow-up Clinician case management: ALL OF THE ABOVE, PLUS:
• Hospitalize child for chelation therapy immediately. Follow-up testing schedule determined by medical provider. The child should not be permitted to return to any environment that would expose him/her to lead.
*While chelation therapy is considered a mainstay in the medical management of children with BLLs  45 μg/dL, it should be used with caution. Unless the clinician is intimately familiar with treatment protocols, he/she should consult with an expert such as one of the following prior to using chelation agents: 7, 8 • 
5-9
As soon as possible, or within 7-14 days 1 month Clinician case management:
• Perform confirmatory testing. Confirm recent known exposure as soon as possible.
• Obtain a maternal BLL prior to delivery, or cord BLL at delivery.
More frequent testing may be indicated based on risk factor history.
• Provide risk reduction education and counsel on avoiding further exposure, including pica behavior.
• Provide nutritional education and refer to WIC as needed. If WIC enrolled, notify local WIC program of EBLL for nutritional assessment.
• Assess nutritional adequacy and counsel on eating a balanced diet with adequate iron and calcium intake, through either diet or supplementation or a combination of both.
LPHA case management:
• Contact patient confirming BLL.
Case Management for BLLs in Pregnant and Lactating Women
• Refer patient to WIC, social services, public assistance, early intervention or housing remediation services if applicable and/or available.
• For lactating women, breastfeeding should be encouraged.
• For occupationally exposed women, discuss personal protective equipment and refer to the Oregon Occupational Public Health Program.
10-14
As soon as possible, or within 7 days 1 month Clinician case management: ALL OF THE ABOVE.
LPHA case management: ALL OF THE ABOVE, PLUS:
• Refer occupationally exposed women to occupational medicine specialist and remove from workplace lead exposure.
15-24
As soon as possible, or within 7 days
Within 1 month and then every 2-3 months.
Clinician case management: ALL OF THE ABOVE.
25-44
Within 1-4 weeks and then every month
Clinician case management: ALL OF THE ABOVE, PLUS:
• For lactating women with BLLs <40, breastfeeding should be encouraged.
• For lactating women with BLLs >40, lactation should be continued, but breast milk should be pumped and discarded until BLLs <40.
LPHA case management: ALL OF THE ABOVE.
>45
As soon as possible, or within 2 days
Within 24 hours and then at frequent intervals depending on clinical interventions and trend in BLLs.
Clinician case management: ALL OF THE ABOVE, PLUS:
• Consultation with a clinician experienced in the management of pregnant women with BLLs in this range is strongly advised.
• Treat as high-risk pregnancy and consult with an expert in lead poisoning on chelation and other treatment decisions.
C. Adult Cases
LPHAs are not expected to conduct case management activities for adults (with the exception of pregnant and lactating women). OHA conducts investigations for adult cases and will alert LPHAs only when there is concern for the health of other household members. 10/18/18 
OHA Case Management for BLLs in Adults 5-9
• Surveillance only.
• No case management in this range unless associated with an exposure event that involves multiple individuals.
• OHA will provide surveillance data to Oregon OSHA.
10-24
• OHA will contact individual via letter after receiving an initial, confirmed BLL in this range. Adult Lead Case Interview form and educational materials will be included with the letter.
• If no contact information is available, then the ordering physician will be contacted by OHA.
Contact information for the individual as well as information regarding occupation/employer will be requested.
>=25
ALL OF THE ABOVE, PLUS • OHA will contact the ordering physician to obtain suspected source of exposure and determine whether other household members, especially children and pregnant and lactating women, may also be at risk of exposure.
• If the exposure is related to the individual's occupation and it is the initial test result in this range, then OHA will notify Oregon OSHA immediately following contact with patient or physician.
>60
• BLLs at this level should be considered urgent.
• The Oregon Poison Center (1-800-222-1222) is a referral source for physicians requesting advice on treatment of adults.
• The greatest concern with adult cases is determining the source of exposure and determining whether other individuals are at risk from the same lead source.
MANAGING SPECIAL SITUATIONS
Lead Exposure during Pregnancy or Breastfeeding
Lead exposure during pregnancy is especially problematic since lead can cross the placenta and interfere with normal development of the fetal brain. High levels of lead during pregnancy can also cause miscarriage, stillbirth, low infant birth weight and premature delivery. Pregnant women can be exposed to lead through all of the sources described previously. Because lead is stored in bone, women who have worked or been exposed to lead in the past may have higher lead levels because lead can be released into the blood during pregnancy. Pregnant or women likely to become pregnant should try to avoid exposure and maintain lead levels below 5 μg/dL and as low as possible. Guidance for pregnant women should focus on proper nutrition, sources of lead exposure and ways to reduce exposure before and during pregnancy. Risk factors such as pica, poor nutrition, country of origin, immigrant status, hobbies and occupations should be discussed. Women exposed occupationally may need special risk-reduction counseling and should be referred to Oregon OSHA or the Lead Poisoning Prevention Program. For more information on lead exposure during pregnancy and breastfeeding, see CDC's Guidelines for the Identification and Management of Lead Exposure in Pregnant and Lactating Women.
Chelation Therapy 10/18/18
Chelating agents solubilize lead, depleting it from soft and hard tissue and thereby reducing its acute toxicity. While chelation therapy is considered a mainstay in the medical management of children with BLLs >45 μg/dL, it should be used with caution. Treatment with chelating agents lowers BLLs, but does not improve scores on tests of cognition, behavior, or neuropsychological functions except in patients with extremely high BLLs. Primary care providers (PCP) should consult with the Oregon Poison Center prior to using chelating agents. In the short term, chelation can redistribute body lead, causing an increase in lead concentrations in soft tissue, including the brain. Some chelators may remove essential minerals, such as calcium, iron, zinc, copper and other trace minerals, as well as lead. There is general agreement that individuals with very high BLLs (in children > 45 µg/dL; in adult >100 µg/dL) should be chelated. Patients with lower BLLs (children <25 µg/dL; adults <65 µg/dL) are usually not chelated unless symptomatic and/or unresponsive after removal from exposure. For patients with in-between BLLs, chelation may or may not be appropriate.
CASE CLOSURE (APPLIES TO CHILD CASES ONLY)
Laboratory Case Closure
Child's BLL has declined to below 5 μg/dL on two consecutive tests at least three months apart.
Administrative Case Closure
Child's case is lost to follow-up. If child/family moves out of state, please notify the Lead Poisoning Prevention Program so they can notify the health department in the state where the child has relocated. The case may also be closed if the medical provider or family does not plan on further follow-up testing. There should be at least three documented attempts to contact the family, whether by phone or letters. If possible, the last attempt to reach the family should be through certified mail.
ENVIRONMENTAL INVESTIGATION PROCEDURES
Environmental Investigation Procedures for Homes of Children with EBLLs
❖ Communicating with parent/guardian: Determine language and literacy. If non-English speaking, arrange for an interpreter. Select appropriate educational materials based on language and reading level.
❖ Schedule Interview/Investigation: Ask the parent/guardian when a good time for an interview would be and who will be present. Most small children have a regular schedule. Work with the family's schedule.
❖ Determine Age of Housing: Contact county tax assessor's office or website to determine age of housing (many people do not know this information). Older housing (pre-1950) is more likely to have lead-based paint and a higher concentration of lead in the paint. Any pre-1978 housing is considered suspect for lead paint.
❖ Visit the Home: 10/18/18 ❖ In All Housing (obtain permission to check suspected items):
 Worn or peeling paint found on furniture, toys or other household objects.
 Vinyl mini-blinds: older ones may still be a source of lead. Advise replacement of vinyl miniblinds if these are not known to be lead-free.
 Painted or vinyl/plastic toys. Look at toy recall list.
 Teeth marks or other signs of chewing on objects or surfaces  Imported, old or improperly glazed pottery or leaded crystal: Advise not to use for food preparation, cooking, serving or storage.
 Lead-containing objects: Items like pewter serving trays, statuary, toys, fishing weights, bullets, leaded glass, etc. Advise against exposure to these objects.
 Lead-related jobs and hobbies: Home remodeling and painting, battery and radiator work, car and boat repair, shooting sports. Advise family members to avoid "take-home" lead exposures by careful hygiene practices and changing contaminated clothes at work. Store and wash work/hobby clothes separately. Restrict child's access to lead activity areas. Employer should check Safety Data Sheets.
 Cultural medicines, home remedies and cosmetics: Look for home remedies or cosmetics that are stored in unmarked containers or have foreign labels. Expect adults to be reluctant to talk about home/cultural remedies.
 Objects containing lead solder, copper plumbing: Recommend that family run water for 30 seconds (or until cold) before use. Advise against using hot tap water for drinking, cooking and especially mixing baby food or formula.
 Other items in the yard or storage that might contain lead: Old boards, other painted building materials or old batteries.
Testing Items and Collecting Samples
Use LeadCheck swabs during EBLL investigations to determine the presence of lead on suspected surfaces and items. When using LeadCheck swabs, follow the manufacturer's instructions.
❖ Testing with LeadCheck Swabs:  Paint: Test any paint in poor condition in a pre-1978 home using a LeadCheck swab. Advise "lead-safe" repair or removal of all paint in poor condition, as well as the repair of any condition that causes peeling paint, leaks, poor ventilation, etc. Information on "lead-safe" remodeling is available at 971-673-0440 or www.healthoregon.org/lead.  Blinds: Test older, vinyl mini-blinds, as they may still be a source of lead. ❖ Exterior Environmental Samples:  Soil samples can only be taken by a Certified Lead Risk Assessor. Contact OHA for assistance.  Check exposed soil and dirt areas, especially where children and pets play. Note location of all play and bare soil areas, as well as bare areas along the dripline of the house and near roadways.  Discuss with the certified risk assessor or OHA recommendations for mitigation of any areas of bare soil that contain elevated or hazardous levels of lead.  Other items: Old boards and furniture, other painted building materials or old batteries. Take note of these areas and advise removal of suspect objects. Lead paint is still sold internationally. Painted toys from international sources may contain lead. Hobby and industrial paint may also contain lead.
SOURCES OF LEAD EXPOSURE
A
B. Dust
Lead paint dust is the most common source of lead exposure for children. Lead in this form is much more easily absorbed. Interior house dust can become contaminated with lead as the result of the deterioration or disturbance of leaded paint, the tracking in of contaminated soil, and the fallout of airborne lead particulate from industrial or vehicular sources. Fine lead dust, and resulting contamination, can be created when painted surfaces rub against each other, such as where double hung windows slide up and down or when doors open and close. Lead in dust is increased after older paint has been disturbed through remodeling, renovation, paint preparation or repair.
C. Occupational Exposures and "Secondary Transmission"
While lead poisoning is not a communicable disease per se, household contacts of persons with occupational, vocational, or other exposures may risk secondary transmission of lead dust or other compounds brought home. Many industries and occupations can expose a worker to lead (Table 5) . Some of the occupations that carry a potential for exposure to lead include remodeling/renovation, painting, building demolition, construction, battery manufacturing and recycling, radiator repair, and bridge construction. Individuals who work in a lead environment may bring lead dust into their 10/18/18 car or home on their clothes and bodies, unintentionally exposing family members. Observation of good hygiene practices is important to avoid bringing lead dust into the home from the work place. These include washing or showering and changing out of work clothes/shoes before leaving for home or entering a vehicle.
If you suspect lead cross-contamination from an occupational source, consult with the OHA CLPP program about a potential OR-OSHA referral.
D. Hobby Sources
Many hobbies use lead (e.g., making or handling lead shot/bullets, fishing weights/sinkers, toy soldiers, stained glass solder, ceramic glazing, etc.). Heating and melting lead is particularly dangerous because of the formation of lead vapor, so respirator use and adequate ventilation are essential to prevent exposure. Other hobbies that carry a potential for exposure to lead include home remodeling and painting, furniture refinishing, welding, auto or boat repair, and target shooting at firing ranges. Hobbyists can protect their families by keeping the hobby activity away from living areas and by showering or changing clothes/shoes before entering the home.
E. Folk Medicines and Cosmetics
Lead has been found in some traditional (folk or home remedies) medicines used by East Indian, Indian, Middle Eastern, West Asian, and Hispanic cultures. Lead and other heavy metals are put into certain folk medicines intentionally because these metals are thought to be useful in treating some ailments. Sometimes lead accidentally gets into the folk medicine during grinding, coloring, or other methods of preparation. Medications such as greta, alarcon, rueda and azarcon, used in the Latino community for stomach ailments (empacho), or "pay-loo-ah," similarly used by many Southeast Asians, may be as much as 90% lead by weight. Cosmetic products are a primary source of lead in Asian and Arab countries. Application of kohl or surma results in lead exposure primarily via handto-eye-to-mouth movement and subsequent ingestion of particles.
F. Tableware
Imported, old, handmade, or poorly glazed ceramic dishes and pottery may contain lead. Lead may additionally be present in leaded crystal, pewter and brass dishware. In these pieces, acid substances may interact chemically with the glaze and accelerate lead release. Therefore, acidic foods (such as orange, tomato and other fruit juices, tomato sauces, wines, and vinegar) stored in improperly glazed containers are potentially the most dangerous. If it is unknown whether a particular tableware item contains lead, the item should not be used to store, cook or serve food or beverages.
G. Water
Most well or city water does not naturally contain lead. Lead in drinking water is an infrequent source of lead poisoning in Oregon. Lead leaches into drinking water from brass faucets, lead solder that connects the pipes, or lead pipes. Hot water is particularly corrosive and should not be used for drinking, cooking, or preparing infant formula. Before any water is consumed, the cold-water tap should be flushed for 30 seconds to two minutes each morning, or after sitting for more than six hours, until there is a noticeable change in temperature of the water.
H. Soil 10/18/18
Soil may contain lead from deteriorating, exterior lead-based paint or deposition from years of leaded gasoline use or industrial emissions. Lead-contaminated soil can be tracked into the home. Children may be exposed to lead by playing in bare soil or from the soil on vegetables planted in a garden. In addition, individuals with pica may eat lead-contaminated soil. Covering bare dirt with grass or bark dust can effectively mitigate lead hazards, unless soil lead levels are extremely high.
I. Miscellaneous Sources
Use of lead solder in the processing of canned foods in the United States has been discontinued; therefore, lead in food has been dramatically reduced. Imported food products may still contain lead as some foreign manufacturers may use lead solder in cans. Food may also be contaminated with lead from the soil during the growing process. Lead has been found in some consumer candies imported from Mexico. Certain candy ingredients such as chili powder and tamarind may be a source of lead exposure. Lead sometimes gets into the candy when processes such as drying, storing, and grinding the ingredients are done improperly. Additionally, lead has been found in the wrappers of some imported candies. The ink of these plastic or paper wrappers may contain lead that leaches into the candy. Lead has also been found in chapulines, dried grasshoppers often imported from Oaxaca, Mexico and prepared in traditional pottery with leaded glazes. Turmeric, a popular spice with purported health qualities, may be contaminated when lead chromate is added to the raw roots to hide pest damage and spots.
There continues to be an ever-increasing array of household products that contain lead, especially imported products. In recent years, lead has been found in vinyl mini-blinds, curtain weights, calcium supplements, hair dyes, crayons, and children's jewelry and toys. Ingestion of any object that may contain lead should be treated as a medical emergency and treatment should include a blood lead test and abdominal x-ray.
Additional information on sources of lead exposure is available on the OHA Lead Program website. 
